LoginRegister
    Health authorities introduce JnJ new Ebola vaccine in CongoHealth authorities introduce JnJ new Ebola vaccine in Congo
    NPPA Relief: Sun Pharma anti-cancer drug Gemcitabine gets price control exemptionNPPA Relief: Sun Pharma anti-cancer drug Gemcitabine gets price control exemption
    Healthcare startup ekincare raises over Rs 25 crore in Series A fundingHealthcare startup ekincare raises over Rs 25 crore in Series A funding
    Eli Lilly-Boehringer diabetes drug Empagliflozin gets thumbs down from FDA panelEli Lilly-Boehringer diabetes drug Empagliflozin gets thumbs down from FDA panel
    Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 croreAurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore
    Merck licenses CRISPR gene-editing technology to EvotecMerck licenses CRISPR gene-editing technology to Evotec
    Mediation between Bayer, plaintiffs seeks to clarify all justified claims: US mediatorMediation between Bayer, plaintiffs seeks to clarify all justified claims: US mediator
    Health Insurance- The Best Backup Plan in TodayHealth Insurance- The Best Backup Plan in Today's Times
    NPPA fixes retail price of 14 drug formulations; DetailsNPPA fixes retail price of 14 drug formulations; Details
    Bristol-Myers Opdivo, Yervoy combination gets USFDA priority review for advanced HCCBristol-Myers Opdivo, Yervoy combination gets USFDA priority review for advanced HCC
    JnJ blockbuster drug Remicade losing ground in Quebec health plan despite court victoryJnJ blockbuster drug Remicade losing ground in Quebec health plan despite court victory
    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in USNatco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X